A 12-year overview of fertility preservation practice in Nordic pediatric oncology centers
Journal of Cancer Survivorship · 2026
DOI: 10.1007/s11764-024-01627-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Survivorship, 2026. Verfasst von Babak Asadi-Azarbaijani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Studies, VID Specialized University, PB 184 Vinderen, 0319, Oslo, Norway. babak.asadi@hotmail.com. Hauptthemen laut MEDLINE: Fertility Preservation, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VID Specialized University.
Abstract (Originalsprache)
Purpose
Fertility preservation is the only option to safeguard fertility following gonadotoxic treatments. This study aimed to provide an updated status on fertility preservation for pediatric cancer patients in the Nordic countries.
Methods
A questionnaire consisting of 14 questions was sent to directors of 18 main pediatric oncology centers in the Nordic countries in 2010 and 2022. We received information regarding indications, guidelines, counseling, and available fertility preservation options.
Results
The response rates were 89% in 2010 and 72% in 2022. The results reveal an increase in clinical practice guidelines on fertility preservation for cancer patients, from 25% in 2010 to 70% in 2022. Counseling on fertility preservation options in 2022 was more specific and offered to most patients who fulfilled indications for fertility preservation (from 19 to 77%). Sperm cryopreservation continues to be the predominant fertility preservation method for pubertal boys in the Nordic countries. However, there has been a notable increase in the availability of testicular tissue preservation for prepubertal boys (0 to 62%). A similar increase in the offer of ovarian tissue preservation for prepubertal girls (0 to 92%) was observed among pediatric cancer patients.
Conclusions
The past decade has shown commendable advancements in fertility preservation for pediatric cancer patients in the Nordic countries. Implications for Cancer Survivors As fertility care evolves globally, continuous assessment of regional practices and challenges is imperative to enhance the quality of care and life for pediatric cancer survivors in the Nordic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health Studies, VID Specialized University, PB 184 Vinderen, 0319, Oslo, Norway. babak.asadi@hotmail.com.
- The Livestock Production Research Centre, Norwegian University of Life Sciences, Aas, Norway.
- Department of Pediatrics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- NORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Förderung
- VID Specialized University
Zitieren
APA
Asadi-Azarbaijani, B., Oskam, I. C., & Jahnukainen, K. (2026). A 12-year overview of fertility preservation practice in Nordic pediatric oncology centers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-024-01627-x
Vancouver
Asadi-Azarbaijani B, Oskam IC, Jahnukainen K. A 12-year overview of fertility preservation practice in Nordic pediatric oncology centers. Journal of Cancer Survivorship. 2026. doi:10.1007/s11764-024-01627-x
BibTeX
@article{AsadiAzarbaijani2026,
author = {Asadi-Azarbaijani, Babak and Oskam, Irma C and Jahnukainen, Kirsi},
title = {A 12-year overview of fertility preservation practice in Nordic pediatric oncology centers},
journal = {Journal of Cancer Survivorship},
year = {2026},
doi = {10.1007/s11764-024-01627-x}
}
EUVIMED